---
schema_version: "secwatch.filing_event.v1"
accession: "0001356576-24-000039"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2024-07-23T23:59:59+00:00"
generated_at: "2026-05-31T17:56:29.980241+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Supernus announces Q2 2024 earnings date: Aug 6 after market close

## Summary
- Q2 2024 financial and business results to be reported after market close on Tuesday, August 6, 2024.
- CEO Jack Khattar and CFO Tim Dec will host a conference call at 4:30 p.m. ET on August 6.
- Live webcast available on Supernus investor relations website; replay accessible for 60 days.
- No preliminary financial results or guidance were provided in this announcement.

## SEC filing metadata
- accession: 0001356576-24-000039
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2024-07-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000135657624000039/0001356576-24-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000135657624000039/supn-20240723.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001356576-24-000039
- JSON: https://secwatch.observer/filing/0001356576-24-000039.json
- Plain text: https://secwatch.observer/filing/0001356576-24-000039.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.